Cargando…
Chlormethine Gel for the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma: In Vitro Release and Permeation Testing
INTRODUCTION: The DNA-alkylating agent chlormethine (CL, or mechlorethamine) is approved in several countries worldwide as a 0.016% w/w topical CL gel formulation, to treat mycosis fungoides cutaneous T-cell lymphoma, with a positive benefit/risk ratio. METHODS: Release profiles of CL from the gel a...
Autores principales: | Giuliano, Claudio, Frizzarin, Stefano, Alonzi, Alessandro, Stimamiglio, Virginia, Ortiz-Romero, Pablo L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588113/ https://www.ncbi.nlm.nih.gov/pubmed/36229764 http://dx.doi.org/10.1007/s13555-022-00813-y |
Ejemplares similares
-
Management of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): focus on chlormethine gel
por: Denis, Daphné, et al.
Publicado: (2019) -
Chlormethine Gel is Efficient and Safe in Mycosis Fungoides Skin Lesions
por: KOUMOURTZIS, Marios, et al.
Publicado: (2022) -
Management of Mycosis Fungoides with Topical Chlormethine/Mechlorethamine Gel: A Columbia University Cutaneous Lymphoma Center Experience
por: GARCIA-SALEEM, Tiffany J., et al.
Publicado: (2021) -
Chlormethine Gel in Combination with Other Therapies in the Treatment of Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: Three Case Reports
por: Lampadaki, Kyriaki, et al.
Publicado: (2021) -
Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data
por: Querfeld, Christiane, et al.
Publicado: (2022)